已发表论文

SOX5 经由 STAT3 信号通路诱导 VEGF 表达引起肺腺癌血管生成

 

Authors Chen X, Zheng Q, Li W, Lu Y, Ni Y, Ma L, Fu Y

Received 7 June 2018

Accepted for publication 24 July 2018

Published 11 September 2018 Volume 2018:11 Pages 5733—5741

DOI https://doi.org/10.2147/OTT.S176533

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Dr Leo Jen-Liang Su

Background and objectives: Angiogenesis is the main cause of lung adenocarcinoma (LAC) poor prognosis. This study aimed to investigate the effect of sex-determining region Y-box protein 5 (SOX5) expression on angiogenesis of LAC and explore its possible mechanism.
Patients and methods: The effect on angiogenesis was tested by tube formation assays using human umbilical vein endothelial cells cocultured with A549 cells. Lentivirus shRNA of SOX5 and lentivirus of SOX5 overexpression system were used to establish LAC cell lines, which expressed SOX5 of different levels. SOX5 downstream signaling targets were analyzed by real-time qPCR and Western blot. We collected 90 LAC cases and the tissues were examined by immunohistochemistry for SOX5 and vascular endothelial growth factor (VEGF).
Results: We found that SOX5 overexpression in A549 cells significantly promoted tube formation capacity of the cocultured human umbilical vein endothelial cells. SOX5 increased VEGF expression and signal transducer activator of transcription 3 phosphorylation; however, SOX5 had no effect on extracellular signal-regulated kinase and protein kinase B pathway. Furthermore, the expression of SOX5 and VEGF had a significantly positive correlation (=0.399, =0.001) according to the tissue microarray data.
Conclusion: These findings suggest that SOX5 induces angiogenesis by activating signal transducer activator of transcription 3/VEGF signaling and confer its candidacy as a potential therapeutic target in LAC.
Keywords: SOX5, VEGF, STAT3, angiogenesis, lung adenocarcinoma, tissue microarray, tube formation




Figure 4 SOX5 and VEGF are positively correlated in lung adenocarcinoma patients’ tumor tissues.